DMPK in Small Molecule Drug Discovery – The What, Why, and When

The Screening Cascade from a DMPK perspective

Successful lead optimization employs integrated drug metabolism and pharmacokinetic (DMPK) screening strategies to:

• Drive successful drug discovery projects
• Identify preclinical proof of concept compounds
• Distinguish candidate molecules with excellent developability profiles

Join this webinar to learn how compounds with good functional activity are evaluated in in vitro and in vivo DMPK studies, providing information on in vitro/in vivo correlations, mitigating potential risks, and informing the design and interpretation of PK/PD studies to demonstrate target engagement.

Webinar Presenters

Mike Briggs, PhD
Science Director, DMPK
Charles River

Have a scheduling conflict? Sign up even if you can’t make it; we’ll share the recording after.